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differences among PTC cases in these two periods.  Conclu-
sions: Over the last decade, there has been an increase in the 
incidence of TC in patients undergoing thyroid surgery. This 
increase is exclusively due to increases in PTC. Our study ver-
ifies the existence of this trend in our geographical area, sim-
ilar to that noted in other parts of the world. 
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 Introduction 
 Numerous studies have shown a worldwide increase in 
the incidence of thyroid cancer (TC) in recent years  [1] 
due to the increased frequency of papillary thyroid carci-
noma (PTC). The reason for this increase is not well un-
derstood, although some authors argue that excessive 
medicalization, sometimes called ‘overdiagnosis’  [2] or 
‘screening effect’ is to blame  [3] . Thus, a greater number 
of ultrasound scans (US) and other imaging techniques, 
along with an increase in the number of thyroidectomies 
for benign conditions and better histological examination 
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 Abstract 
 Background: Numerous studies have shown an increase in 
the incidence of thyroid cancer (TC) in recent years.  Objec-
tives: In this paper, we reviewed the incidence of TC in a se-
ries of patients undergoing thyroid surgery at a single insti-
tution over a 10-year period.  Patients and Methods: The co-
horts were divided into two periods (2001–2005 and 
2006–2010) with the purpose of comparing various clinico-
pathologic variables.  Results: A total of 1,263 patients were 
included. A significant increase in the number of malignan-
cies was shown in the second period, namely 90 cases in 
2001–2005 (15.2% of all interventions) compared to 163 cas-
es in 2006–2010 (24.3%) (p < 0.001). These differences were 
attributed to an increase in papillary thyroid carcinoma 
(PTC), as there were 66 PTC cases in the first period (11.13% 
of thyroidectomies performed) compared to 129 cases in the 
second period (19.25%). There were no clinicohistological 
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of surgical specimens, have led to the diagnosis of PTC 
cases with low clinical impact  [4–9] . This argument is 
corroborated by epidemiological data which suggest that 
the increase in the diagnosis of PTC is at the expense of 
smaller tumors, especially microcarcinomas (PTC <1 cm) 
 [10, 11] . Other authors, however, point to a real increase 
in the incidence of PTC  [12, 13] , which could be related 
to the effect of ionizing radiation or iodine supplementa-
tion in the general population  [14–16] . Other reasons, 
such as hormonal factors  [17] , the increased incidence of 
obesity  [18] , environmental toxins such as polybrominat-
ed diphenyl ethers  [19] , or changing histological criteria 
for PTC  [20] have also been postulated.
 The aim of this study was to retrospectively analyze a 
series of thyroidectomies performed at our center over 
the course of a decade (2001–2010) and to determine the 
incidence of TC in these cases.
 Material and Methods 
 Between January 2001 and December 2010, a total of 1,323 sub-
jects underwent thyroid surgery. Patients with previous thyroid 
surgery or incomplete clinical information were excluded. All in-
cluded patients had a solitary nodule or a multinodular goiter de-
tected by clinical examination, US, or both. Preoperatively, an US 
confirmed nodular thyroid disease in all cases. A fine-needle aspi-
ration biopsy (FNAB) was performed for thyroid nodules >1 cm 
and for nodules <1 cm with suspicious US features. Thyroidecto-
my was prescribed for patients with malignant, suspicious, or re-
petitive indeterminate nodules according to FNAB results. More-
over, surgery was indicated for benign disease when local symp-
toms were present or for esthetic reasons.
 Total cohorts were separated into two groups: group 1 included 
patients operated on between 2001 and 2005, whereas group 2 in-
cluded patients operated on between 2006 and 2010. In both 
groups, demographic characteristics, type of surgery (total thy-
roidectomy vs. non-total thyroidectomy), preoperative serum lev-
els of thyrotropin (TSH), presence of thyroid antibodies, and inci-
dence of TC according to histological types were compared. His-
tological variants were classified as differentiated TC (DTC), 
including PTC and follicular thyroid carcinoma (FTC), and non-
DTC, which included all other types of malignancies (medullary 
carcinoma, undifferentiated carcinoma, metastatic thyroid, and 
lymphoma). Finally, we compared the characteristics of PTC de-
tected in both periods in relation to the following variables: age, 
preoperative TSH value, tumor size, percentage of microcarcino-
mas, mutlifocality, lymph node metastases, associated thyroiditis, 
and mode of diagnosis (incidental vs. non-incidental). We defined 
an incidental diagnosis as PTC diagnosed at final histology in a 
patient whose reason for intervention was benign thyroid disease. 
Quantitative variables were expressed as mean and standard de-
viation, and categorical variables were expressed as frequencies 
and proportions. Statistical analysis was performed using the χ 2 
test for categorical variables and the Student t test for quantitative 
variables. p values  ≤ 0.05 were considered statistically significant.
 Results 
 A total of 1,263 cases, 1,023 women and 240 men (av-
erage age of 51.9 years), were included retrospectively. 
Previous to surgery all patients underwent FNA. Thy-
roidectomy was prescribed for malignancy or suspicious 
of malignancy in 221 patients (17.5%). Final histological 
examination revealed the presence of TC in 253 cases 
(20%), and of these, 216 patients had DTC (195 PTC cas-
es, 21 FTC cases) ( fig. 1 ). The mean size of the PTC was 
15.4 (±12.6) mm, and no significant differences in size 
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 Fig. 1. TC in patients undergoing thyroid surgery during the pe-
riod 2001–2010 (see text for details). 
 Fig. 2. Mean size distribution of PTC over the decade. 
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 Group 1 included 593 cases (487 women and 106 men) 
with a mean age of 51.8 (±14.2) years. In group 2, there 
were 670 subjects (536 females and 134 males) with a 
mean age of 51.9 (±16.3) years. There were no significant 
differences in gender or age in both groups. However, 
there was a significant increase in the number of malig-
nancies in the second period: 90 TC cases (15.2% of all 
interventions) in group 1 compared to 163 cases (24.3%) 
in group 2 (p < 0.001). Differences were due to a signifi-
cant increase in the number of DTC cases: 73 (12.1%) in 
the first half of the decade versus 143 (21.3%) in the sec-
ond half (p < 0.001). Within DTC cases, there was no sig-
nificant variation in the number of FTC cases: 7 (1.2%) in 
group 1 compared to 14 (2%) in group 2 (p = 0.29). Thus, 
the observed increase in the incidence of TC was due sole-
ly to an increase in PTC: 66 cases between 2001 and 2005, 
accounting for 11.13% of all thyroidectomies performed, 
compared to 129 cases between 2006 and 2010, which ac-
counted for 19.25% of all surgical interventions. Non-
DTC thyroid malignancies included 13 and 11 medullary 
TCs, 5 and 3 anaplastic TCs, and 1 and 6 other tumors 
(secondary metastasis and primary thyroid lymphoma) 
in groups 1 and 2, respectively.
 There were no significant differences in variables an-
alyzed between the two 5-year periods. The preopera-
tive TSH value was 1.8 (±5.9) mU/dl in group 1 patients 
and 1.5 (±1.9) mU/dl in group 2 patients. Although not 
statistically significant, there was an increase in the 
number of total thyroidectomies in the second half of 
the decade: 409 cases (69%) between 2001 and 2005 
compared to 494 cases (73.7%) between 2006 and 2010 
(p = 0.06). In both groups, 73% of patients had no thy-
roid antibodies.
 Table 1 summarizes the characteristics of the PTC cas-
es in both periods. It can be seen that there were no dif-
ferences in any of the observed variables, which included 
age, preoperative TSH value, tumor size, percentage of 
microcarcinomas, multifocality, metastatic disease, thy-
roiditis, and mode of diagnosis. Thus, there were a total 
of 84 incidental cancers, 31 in the first period (47%) and 
53 in the second period (41%) (p = 0.43). These numbers 
represented 7.6% of the patient cohort with total thyroid-
ectomies in group 1 and 10.7% of the patient cohort with 
total thyroidectomies in group 2 (p = 0.1).
 In addition, only 6 cases (9%) in the first period and 12 
cases (9%) in the second period were non-incidental mi-
crocarcinomas.
 Discussion 
 This study supports, in our environment, the trend of 
increased incidence of TC, due to an increase in PTC, 
during the first decade of the century in the cohort of pa-
tients who underwent thyroid surgery. The percentage of 
PTC increased by almost 10% between 2006 and 2010 
compared to 2001 and 2005.
 One presumed reason for this increase in the incidence 
of PTC is the screening effect, namely the higher and bet-
ter performance of various tests in the general popula-
tion, such as US and FNABs of thyroid nodules  [5–9] , 
which has led to increased diagnosis of PTC. This argu-
ment is corroborated by epidemiological data suggesting 
an increase in PTC diagnosis at the expense of smaller 
PTCs, especially microcarcinomas  [10, 11, 21] . These tu-
mors are of unknown clinical significance. It has been hy-
pothesized that if the entire pool of occult PTC were iden-
tified antemorten, the resulting ascertainment bias could 
result in a 50-fold increase in the apparent incidence of 
PTC  [22] . In our study, we did not observe an increase in 
microcarcinomas, and the average size of PTC did not 
change over the decade. Furthermore, although it is pos-
tulated as being more frequent, not all reports found that 
the increase in PTC was only at the expense of smaller 
PTCs  [23, 24] . Davies and Welch  [10] found, based on 
data from the National Cancer Institute’s Surveillance, 
Epidemiology and End Results (SEER) Program, that be-
tween 1988 and 2002, the largest percent increases in PTC 
were in tumors <2 cm. Hughes et al.  [2] also analyzed the 
SEER registry and found that the greatest increase in PTC 
occurred in patients older than 45 years with microcarci-
nomas; the authors attributed these findings to overdiag-
nosis. However, using the same database, Zhu et al.  [25] 
 Table 1.  Characteristics of the PTC cases in both periods (2001 – 






Age (mean ± SD), years 46.2 ± 12.9 49.2 ± 15.3 0.15
TSH (mean ± SD), mU/l 1.78 ± 2.0 2.22 ± 2.5 0.26
Size (mean ± SD), mm 15.7 ± 13.1 15.2 ± 12.4 0.79
Microcarcinomas, % 48.5 45.7 0.71
Multifocality, % 44 46.5 0.73
Bilaterality, % 17 27 0.09
Lymph node M1, % 26 36 0.10
Thyroiditis, % 31 32 0.85
Incidental diagnosis, % 47 41 0.43
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found that the rate of the age-adjusted incidence showed 
a significant increase in PTC for all tumor sizes between 
1988 and 2003. In a detailed analysis conducted by Ene-
wold et al.  [13] on the same SEER program, the authors 
found that PTCs >5 cm increased 222% (similar to the 
248% in tumors <1 cm) in American white women. Sim-
ilarly, Yu et al.  [26] compared the incidence of PTC in two 
different periods (1992–1996 and 2000–2004) and found 
a significant increase in all tumor sizes. Also, in an Italian 
study that compared the most recent periods (1998–2003 
and 2004–2009), the authors did not find differences in 
the percentage of microcarcinomas  [27] . Finally, Morris 
and Myssiorek  [12] reported a similar increase in the per-
centage of cases with extrathyroidal extension, a factor 
that does not support the screening effect as the cause of 
the observed changes.
 Similar to other studies on the incidence of neoplasms, 
data  are recorded in relation to the reference population 
(usually per 100,000 population). Since a high percentage 
of PTC cases are incidentally diagnosed after thyroidec-
tomies for benign disease, the population incidence of 
thyroid interventions and the extent of the thyroidecto-
my may influence this kind of malignancy  [28–31] . In a 
recent report, Sassolas et al.  [32] found that 64% of mi-
crocarcinomas are diagnosed incidentally; in a study by 
Alevizaki et al.  [33] , this figure rose to 88%. In the present 
study, the frequency of TC was not related to the general 
population, but to cases of thyroidectomies performed. 
We observed an increment in the percentage of interven-
tions that were positive for malignancy, reaching 24.3% 
in the second period. Using a similar design, Sassolas et 
al.  [34] found that 22% of all thyroid interventions for any 
cause were related to TC.
 It has been proposed that the increase in PTC may be 
due to an improvement in the selection of patients re-
ferred for surgery  [3] . However, the fact that incidental 
and non-incidental cases increased in parallel does not 
support this hypothesis. In the present study, the percent-
age of incidental PTC cases showed no differences in the 
two periods analyzed. The combination of lack of spe-
cific increasing trends of smaller tumors and stability in 
the percentage of cases incidentally diagnosed seems to 
favor a true increase in the incidence of PTC. Moreover, 
in most recent years, there have been no substantial 
changes in the diagnosis and therapeutic management of 
patients with nodular thyroid disease. Thus, it appears 
that the increase in PTC is due to both improvements in 
diagnostic techniques and their high use (overdiagnosis), 
and a real increase in the incidence of PTC. The etiology 
of this globally verified phenomenon has not been estab-
lished.
 There are some limitations to our study. The study pop-
ulation is not representative of the general population nor 
is it a population with thyroid disease. Rather, as was men-
tioned above, it contains patients who have been thyroid-
ectomized. Therefore, we cannot rule out bias caused by 
changes in social or demographic parameters in the refer-
ence population. Moreover, the comparison periods were 
two successive 5-year periods, a very short time interval for 
the identification of significant changes in incidence 
trends. However, the relatively short study period also re-
duced the likelihood of changes in socio-demographic sta-
tus, referral criteria, surgical indications, and diagnostic 
(clinical and histological) and therapeutic protocols. 
Therefore, this variability could be higher in studies that 
compare longer periods and thus produce greater bias.
 In conclusion, this study suggested an increase in the 
number of TC cases in the first decade of the century in 
patients undergoing thyroid surgery.
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